Old commercial enzyme-linked immunoassay (ELISA) tests gave uncertain and contradictory results in assessing the presence and level of IFNα molecules in the serum of patients with autoimmune diseases, probably because of the simultaneous presence of different IFN subtypes [36]. The gene discussed is IFNA1; the disease is autoimmune disease.